Pharmaceutical Intermediates Market OverviewThe global pharmaceutical intermediates market is witnessing steady expansion as pharmaceutical manufacturing scales worldwide. Valued at approximately USD ...

Transformation is more than another manufacturing buzzword. Today, 98 percent of manufacturers have a digital initiative in ...

Held in Guangzhou from December 11, the 2025 Global Technology Innovation Conference (TIC) served as the flagship stage for the company to unveil its latest advancements in integrated technology. The ...

MES software evolved from rigid, expensive platforms into flexible, cloud-based solutions that bridge business strategy with ...

Car buyers in the UK should always obtain an official history check to avoid purchasing a used car misrepresented by its ...

Reviving and restoring America’s migrating manufacturing base was one of the marquee pledges of President Donald Trump’s successful 2024 campaign. But this renaissance has yet to materialize and ...

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.

Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments. Many of those projects have centered on later stages of the production ...

Under President Donald J. Trump’s bold leadership, America’s manufacturing sector is surging forward with unprecedented momentum. In the past week alone, major corporations have unveiled billions of ...

What if creating stunning, professional-grade videos was as simple as typing a few words or uploading an image? At OpenAI DevDay 2025, the unveiling of the Sora 2 API promised to transform the way we ...

New state-of-the-art active pharmaceutical ingredient (API) facility will manufacture immunology, oncology and neuroscience medicines Facility expected to be fully operational and serving patients by ...